The effects of oral pancreatic enzymes (Creon 10 capsule) on steatorrhea: A multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis

Pancreas

Volumn 33, Issue 2, 2006, Pages 156-162

  Safdi, Michael ^a   Bekal, Pradeep K ^a   Martin, Stephen ^a   Saeed, Zahid A ^a   Burton, Frank ^b   Toskes, Phillip P ^c  

^a Greater Cincinnati Gastroenterology Associates   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

Chronic pancreatitis; Clinical trial; Creon 10; Pancreatic enzyme replacement; Steatorrhea

Indexed keywords

KREON; PLACEBO;

ABDOMINAL PAIN; ACCIDENTAL INJURY; ADULT; AGED; ANOREXIA; ARTICLE; ASTHENIA; BACKACHE; BRONCHITIS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION HABIT; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FAT EXCRETION; FECES ANALYSIS; FEMALE; HUMAN; LIPID ABSORPTION; LIPID METABOLISM; MALE; MYALGIA; NAUSEA; NECK PAIN; NEPHROSCLEROSIS; OBSTRUCTIVE JAUNDICE; PAIN; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM DISEASE; SCORING SYSTEM; SKIN DISEASE; STATISTICAL SIGNIFICANCE; STEATORRHEA; TREATMENT OUTCOME; TREMOR;

ADMINISTRATION, ORAL; ADULT; AGED; CAPSULES; DELAYED-ACTION PREPARATIONS; DIETARY FATS; FECES; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL ABSORPTION; LIPIDS; MALE; MIDDLE AGED; PANCREATITIS, CHRONIC; PANCRELIPASE; PATIENT SATISFACTION; PLACEBOS; STEATORRHEA; TREATMENT OUTCOME;

EID: 33746853011     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000226884.32957.5e     Document Type: Article

References (25)

1. DiMagno EP, Malagelada JR, Go VL. Relationship between alcoholism and pancreatic insufficiency. Ann N Y Acad Sci. 1975;252:200-207.
2. Keller J, Layer P. Pancreatic enzyme supplementation therapy. Curr Treat Options Gastroenterol. 2003;6(5):369-374.
3. Greenberger NJ. Enzymatic therapy in patients with chronic pancreatitis. Gastroenterol Clin North Am. 1999;28(3):687-693.
4. Layer P, Keller J. Lipase supplementation therapy: standards, alternatives, and perspectives. Pancreas. 2003;26(1):1-7.
5. Creon 10 product description. Physicians Desk Reference. Montvale, NJ: Medical Economics Data Production Company; 2004.
6. Chowdhury RS, Forsmark CE. Review article: pancreatic function testing. Aliment Pharmacol Ther. 2003;17(6):733-750.
7. Maartense S, Ledeboer M, Masclee AA. Chronic pancreatitis: relation between function and morphology. Dig Liver Dis. 2004;36(1):61-67.
8. Bozkurt T, Braun U, Leferink S, et al. Comparison of pancreatic morphology and exocrine functional impairment in patients with chronic pancreatitis. Gut. 1994;35:1132-1136.
9. Kolbel C, Layer P, Hotz J, et al. Effect of an acid protected, micro-encapsulated pancreatin preparation on pancreatogenic steatorrhea. Med Klin (Munich). 1986;81(3):85-86.
10. Meyer JH, Elashoff L, Porter-Fink V, et al. Human postprandial gastric emptying of 1-3 millimeter spheres. Gastroenterology. 1988;94:1315-1325.
11. Hendeles L, Dorf A, Stecenko A, et al. Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity. JAMA. 1990;263(18):2459-2461.
12. Beverley DW, Kelleher J, MacDonald A, et al. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child. 1987;62(6):564-568.
13. Brady MS, Rickard K, Yu PL, et al. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. J Am Diet Assoc. 1992;92(7):813-817.
14. Dutta SK, Rubin J, Harvey J. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology. 1983;84(3):476-482.
15. Gan KH, Heijerman HG, Geus WP, et al. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients. Aliment Pharmacol Ther. 1994;8(6):603-607.
16. Halm U, Loser C, Lohr M, et al. A double-blind, randomized, multicenter, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency. Aliment Pharmacol Ther. 1999;13(7):951-957.
17. Lancellotti L, Cabrini G, Zanolla L, et al. High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial. J Pediatr Gastroenterol Nutr. 1996;22(1):73-78.
18. Malesci A, Gaia E, Fioretta A, et al. No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis. Scand J Gastroenterol. 1995;30(4):392-398.
19. Mischler EH, Parrell S, Farrell PM, et al. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis. Am J Dis Child. 1982;136(12):1060-1063.
20. Morrison G, Morrison JM, Redmond AO, et al. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther. 1992;6(5):549-555.
21. Patchell CJ, Desai M, Weller PH, et al. Creon 10,000 Minimicrospheres vs. Creon 8,000 microspheresVan open randomised crossover preference study. J Cyst Fibros. 2002;1(4):287-291.
22. Regele S, Henker J, Munch R, et al. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation. J Pediatr Gastroenterol Nutr. 1996;22(1):68-72.
23. Robinson PJ, Olinsky A, Smith AL, et al. High compared with standard dose lipase pancreatic supplement. Arch Dis Child. 1989;64(1):143-145.
24. Santini B, Antonelli M, Battistini A, et al. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis. Dig Liver Dis. 2000;32(5):406-411.
25. Stern RC, Eisenberg JD, Wagener JS, et al. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency. Am J Gastroenterol. 2000;95(8):1932-1938.